Top

Osteoporosis International

Published in:

01-12-2011 | Original Article

Testing and treatment for osteoporosis following hip fracture in an integrated U.S. healthcare delivery system

Authors: A. Shibli-Rahhal, M. S. Vaughan-Sarrazin, K. Richardson, P. Cram

Published in: Osteoporosis International | Issue 12/2011

Abstract

Summary

Older veterans with acute hip fracture do not receive adequate evaluation and treatment for osteoporosis, irrespective of their age and underlying health status.

Introduction

Hip fractures are a serious complication of osteoporosis, leading to high mortality and morbidity. Prior studies have found significant undertreatment of osteoporosis in women with hip fracture. We examined the rate of bone density (BMD) testing and osteoporosis treatment among a predominantly male population hospitalized with hip fractures.

Methods

We conducted a retrospective cohort study of patients age 65 years and older hospitalized in U.S. Department of Veterans Affairs (VA) hospitals with hip fracture (N = 3,347) between 1 October, 2004 and 30 September, 2006. The primary outcome was receipt of BMD testing or initiation of pharmacotherapy within 12 months of fracture.

Results

The mean age of the study population was 79.0 years (SD = 6.7), 96.5% were male, and 83.3% were white. Only 1.2% of hip fracture patients underwent BMD testing and 14.5% received osteoporosis therapy within 12 months of fracture. Among fracture patients with minimal comorbid illness (N = 756) only 1.6% underwent BMD testing and 13.0% received pharmacotherapy. In logistic regression models, treatment rates were higher for women compared to men (odds ratio, 3.30; 95% CI, 2.16–5.04) and lower for blacks compared to whites (odds ratio, 0.67; 95% CI, 0.45–0.99).

Conclusions

Evaluation and treatment of osteoporosis among patients with fractures is suboptimal even in an integrated healthcare delivery system with generous pharmaceutical coverage. This study suggests that the undertreatment of osteoporosis demonstrated in the private sector is also present within the VA.

Bergström U, Bjornstig U, Stenlund H, Jonsson H, Svensson O (2008) Fracture mechanisms and fracture pattern in men and women aged 50 years and older: a study of a 12-years population-based register, Umea, Sweden. Osteoporos Int 19:1267–1273PubMedCrossRef

Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20:1633–1650PubMedCrossRef

Beringer TR, Clarke J, Elliott JR, Marsh DR, Heyburn G, Steele IC (2006) Outcome following proximal femoral fracture in Northern Ireland. Ulster Med J 75:200–206PubMed

Koval KJ, Zuckerman JD (1994) Functional recovery after fracture of the hip. J Bone Joint Surg Am 76:751–758PubMed

Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedCrossRef

van Staa TP, Leufkens HG, Cooper C (2002) Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporos Int 13:624–629PubMedCrossRef

Colón-Emeric CS, Sloane R, Hawkes WG (2000) The risk of subsequent fractures in community dwelling men and male veterans with hip fracture. Am J Med 109:324–326PubMedCrossRef

National Osteoporosis Foundation (2010) Clinician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC

Juby AG, De Geus-Wenceslau CM (2002) Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int 13:205–210PubMedCrossRef

10.

Follin SL, Black JN, McDermott MT (2003) Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture. Pharmacotherapy 23:190–198PubMedCrossRef

11.

Torgerson DJ, Dolan P (1998) Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 57:378–379PubMedCrossRef

12.

Kamel HK, Hussain MS, Tariq ST, Perry HM III, Morley JE (2000) Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 109:326–328PubMedCrossRef

13.

Andrade SE, Majumdar SR, Chan A, Buist DSM, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH (2003) Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 163:2052–2057PubMedCrossRef

14.

Siris ES, Bilezikian JP, Rubin MR, Black DM, Bockman RS, Bone HG, Hochberg MC, McClung MR, Schnitzer TJ (2003) Pins and plasters aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab 88:3482–3486PubMedCrossRef

15.

Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778PubMedCrossRef

16.

Harrington JT, Broy SB, Derosa AM, Licata AA, Shewmon DA (2002) Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum 47:651–654PubMedCrossRef

17.

Kamel HK, Bida A (2004) Secondary prevention of hip fractures in veterans: can we do better? J Am Geriatr Soc 52:647–648PubMedCrossRef

18.

Riley RL, Cames ML, Gudmundsson A, Elliott ME (2002) Outcomes and secondary prevention strategies for male hip fractures. Ann Pharmacother 36:17–23PubMedCrossRef

19.

Colo'n-Emeric C, Yballe L, Sloane R, Pieper CF, Lyles KW (2000) Expert physician recommendations and current practice patterns for evaluating and treating men with osteoporotic hip fracture. J Am Geriatr Soc 48:1261–1263

20.

Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139PubMedCrossRef

21.

Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8–27PubMedCrossRef

22.

Kaufman JD, Bolander ME, Bunta AD, Edwards BJ, Fitzpatrick LA, Simonelli C (2003) Barriers and solutions to osteoporosis care in patients with a hip fracture. J Bone Joint Surg Am 85-A:1837–1843PubMed

23.

Levinson MR, Clay FJ (2009) Barriers to the implementation of evidence in osteoporosis treatment in hip fracture. Int Med J 39:199–202CrossRef

24.

Sheehan J, Mohamed F, Reilly M, Perry IJ (2000) Secondary prevention following fractured neck of femur: a survey of orthopaedic surgeons practice. Ir Med J 93:105–107PubMed

25.

Simonelli C, Killeen K, Mehle S, Swanson L (2002) Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc 77:334–338PubMedCrossRef

26.

Roerholt C, Eiken P, Abrahamsen B (2009) Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteoporos Int 20:299–307PubMedCrossRef

27.

Kiezbak GM, Beinart GA, Perser K, Ambrose CG, Sift SJ, Heggeness MH (2002) Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162:2217–2222CrossRef

28.

Panneman MJ, Lips P, Sen SS, Herings RM (2004) Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int 15:120–124PubMedCrossRef

29.

Al Attia H, Adams B (2007) Osteoporosis in men: are we referring enough for DXA and how? Clin Rheumatol 26:1123–1126PubMedCrossRef

30.

Madeo B, Zirilli L, Caffagni G, Diazzi C, Sanguanini A, Pignatti E, Carani C, Rochira V (2007) The osteoporotic male: overlooked and undermanaged? Clin Interv Aging 2:305–312PubMed

31.

Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fracture. Osteoporos Int 17:1726–1733PubMedCrossRef

32.

Ringe JD, Farahmand P, Faber H, Dorst A (2009) Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. Rheumatol Int 29:311–315PubMedCrossRef

33.

Kaufman JM, Orwoll E, Goemaere S, San Martin J, Hossain A, Dalsky GP, Lindsay R, Mitlak BH (2005) Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporos Int 16:510–516PubMedCrossRef

34.

Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S, Recurrent Fracture Trial HORIZON (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1809PubMedCrossRef

35.

Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604–610PubMedCrossRef

36.

McQueen L, Mittman BS, Demakis JG (2004) Overview of the Veterans Health Administration (VHA) Quality Enhancement Research Initiative (QUERI). J Am Med Inform Assoc 11:339–343PubMedCrossRef

37.

Department of Veterans Affairs Office of Inspector General (2010) Healthcare Inspection Management of osteoporosis in veterans with fractures; Rpt # 09-03138-191. http://www4.va.gov/oig/54/reports/VAOIG-09-03138-191.pdf. Accessed 12 November 2010.

38.

Feldstein A, Elmer PJ, Smith DH, Herson M, Orwoll E, Chen C, Aickin M, Swain MC (2006) Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc 54:450–457PubMedCrossRef

39.

Mjumdar SR, Johnson JA, McAlister FA, Bellerose D, Russell AS, Hanley DA, Morrish DW, Maksymowych WP, Rowe BH (2008) Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ 178:569–575CrossRef

40.

Majumdar SR, Beaupre LA, Harley CH, Hanley DA, Lier DA, Juby AG, Maksymowych WP, Cinats JG, Bell NR, Morrish DW (2007) Use of a case manager to improve osteoporosis treatment after hip fracture. Results of a randomized controlled trial. Arch Intern Med 167:2110–2115PubMedCrossRef

41.

Johnell O, Kanis JA, Odén A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jönsson B (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175–179PubMedCrossRef

42.

Jones G, Warr S, Francis E, Greenaway T (2005) The effect of a fracture protocol on hospital prescriptions after minimal trauma fractured neck of the femur: a retrospective audit. Osteoporos Int 16:1277–1280PubMedCrossRef

Title: Testing and treatment for osteoporosis following hip fracture in an integrated U.S. healthcare delivery system
Authors: A. Shibli-Rahhal
M. S. Vaughan-Sarrazin
K. Richardson
P. Cram
Publication date: 01-12-2011
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 12/2011
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-011-1536-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Testing and treatment for osteoporosis following hip fracture in an integrated U.S. healthcare delivery system

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2011

Bone health in multiple sclerosis

In peripubertal girls, artistic gymnastics improves areal bone mineral density and femoral bone geometry without affecting serum OPG/RANKL levels

Re: The calcium scare: what would Austin Bradford Hill have thought?

Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study

The calcium scare—what would Austin Bradford Hill have thought?

Maintaining femoral bone density in adults: how many steps per day are enough?